
Danicamtiv
CAS No. 1970972-74-7
Danicamtiv( MYK-491 | SAR 440181 )
Catalog No. M23890 CAS No. 1970972-74-7
Danicamtiv is an inotropic agent and it also is a selective allosteric activator of cardiac myosin. Danicamtiv increases cardiac systolic function and preserves mechanical efficiency.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 260 | In Stock |
![]() ![]() |
10MG | 430 | In Stock |
![]() ![]() |
25MG | 710 | In Stock |
![]() ![]() |
50MG | 972 | In Stock |
![]() ![]() |
100MG | 1332 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameDanicamtiv
-
NoteResearch use only, not for human use.
-
Brief DescriptionDanicamtiv is an inotropic agent and it also is a selective allosteric activator of cardiac myosin. Danicamtiv increases cardiac systolic function and preserves mechanical efficiency.
-
DescriptionDanicamtiv is an inotropic agent and it also is a selective allosteric activator of cardiac myosin. Danicamtiv increases cardiac systolic function and preserves mechanical efficiency.
-
In Vitro——
-
In VivoDanicamtiv selectively enhances cardiac actomyosin activity, the molecular force‐generating unit of the sarcomere, prolonging contraction while preserving actin–myosin detachment, allowing relaxation, and without impacting Ca2+ homeostasis.
-
SynonymsMYK-491 | SAR 440181
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetMyosin
-
Recptorhuman cardiac
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1970972-74-7
-
Formula Weight435.42
-
Molecular FormulaC16H20F3N5O4S
-
Purity>98% (HPLC)
-
SolubilityDMSO:50mg/ml (114.83mM; Need ultrasonic)
-
SMILESC[C@@](C(CC1)CCN1C(Nc1nocc1)=O)(F)S(c1cn(C)nc1C(F)F)(=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sarah Fernandes, et al. Abstract 15707: MYK-491, a Novel Small-Molecule Cardiac Myosin Activator Increases Cardiac Systolic Function and Preserves Mechanical Efficiency: Pre-Clinical in vivo and in vitro Evidence. Circulation. 2019;140:A15707
molnova catalog



related products
-
BTS
A highly specific myosin II ATPase inhibitor; inhibits the Ca2+-stimulated S1 ATPase, and reversibly blocked gliding motility.
-
Danicamtiv
Danicamtiv is an inotropic agent and it also is a selective allosteric activator of cardiac myosin. Danicamtiv increases cardiac systolic function and preserves mechanical efficiency.
-
BHC
BHC (Myosin inhibitor BHC) is a small-molecule screen of skeletal muscle myosin inhibitor.